Stay updated on Gantenerumab Long-term Safety in AD Clinical Trial

Sign up to get notified when there's something new on the Gantenerumab Long-term Safety in AD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gantenerumab Long-term Safety in AD Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Locations section expanded to include new regional sites across the US and internationally (Arizona, California, Florida, Michigan, New York, North Carolina, Oklahoma, Tennessee, Texas, South Australia, Victoria, Nova Scotia, Ontario, Emilia-Romagna, Lombardy, Mexico City, Nuevo León, Sankt-Peterburg, Alicante, Barcelona) and updated to v3.3.3; some previous location groupings were removed.
    Difference
    2%
    Check dated 2025-12-24T15:10:21.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    29 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    The page shows a new revision label 'Revision: v3.3.2' in place of the previous 'Revision: v3.2.0'. This looks like a frontend update and does not modify study details or other substantive content.
    Difference
    0.0%
    Check dated 2025-11-24T21:33:20.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Removed the top banner notice about government funding and operating status, which does not affect the study data or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T19:51:33.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record now indicates termination of the study of gantenerumab for Alzheimer's disease following a pre-planned analysis. This update changes the study status and completion information shown on the page.
    Difference
    0.3%
    Check dated 2025-11-03T13:49:49.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Significant update: new operating-status notice and version bump to v3.2.0; previous v3.1.0 tag removed. Core content impacted by the new status information.
    Difference
    3%
    Check dated 2025-10-06T04:21:03.000Z thumbnail image
  9. Check
    100 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no other substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T23:42:35.000Z thumbnail image

Stay in the know with updates to Gantenerumab Long-term Safety in AD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gantenerumab Long-term Safety in AD Clinical Trial page.